Xponance’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,656
Closed -$2.49M 1383
2024
Q1
$2.49M Sell
7,656
-245
-3% -$60.1K 0.03% 461
2023
Q4
$1.51M Sell
7,901
-375
-5% -$70.9K 0.02% 546
2023
Q3
$1.65M Buy
8,276
+32
+0.4% +$7.57K 0.02% 511
2023
Q2
$2.35M Buy
8,244
+2,501
+44% +$695K 0.03% 433
2023
Q1
$1.25M Sell
5,743
-16
-0.3% -$3.12K 0.02% 579
2022
Q4
$1.18M Buy
5,759
+7
+0.1% +$1.77K 0.02% 583
2022
Q3
$1.6M Buy
5,752
+10
+0.2% +$2.54K 0.03% 439
2022
Q2
$1.1M Buy
5,742
+3,900
+212% +$688K 0.02% 548
2022
Q1
$382K Buy
1,842
+13
+0.7% +$2.14K 0.01% 975
2021
Q4
$326K Buy
1,829
+4
+0.2% +$789 0.01% 1027
2021
Q3
$376K Sell
1,825
-23
-1% -$4.52K 0.01% 990
2021
Q2
$351K Buy
+1,848
New +$302K 0.01% 1034

Other funds holding SWAV

Xponance's SWAV Position: Q2 2024 in Review

Xponance sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 7,656 shares — an estimated $2.49M sold.

Xponance first reported a position in SWAV in Q2 2021 and held it in 12 quarters. The position peaked at $2.49M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Xponance reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Xponance sold 7,656 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.49M.
  • Xponance first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Xponance's Shockwave Medical, Inc. Common Stock position peaked at $2.49M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.